retatrutide weight loss trial shows significant in obesity and knee osteoarthritis | Ahmad Bahareth, MD posted on the topic VisualAbstract: Retatrutide reduces body weight

[16] [17] Semaglutide (as Wegovy) is further indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with obesity (initial BMI 30 kg/m 2 ) or who are overweight (initial BMI 27 kg/m 2 ) and have at least one weight-related comorbidity such as dysglycemia (prediabetes or type 2 diabetes), hypertension, dyslipidemia, or cardiovascular disease

If you believe your adrenals are part of your Hashimotos root causes, Id also recommend checking out my newest book, Adrenal Transformation Protocol

Across the cagrilintide clinical program, the dominant tolerability issues have been gastrointestinal: nausea, reduced appetite, constipation, and, less commonly, vomiting a profile shared with pramlintide and with GLP-1 agonists, and mechanistically expected from a compound that slows the stomach and engages the area postrema

Melatonin has been shown to also inhibit MMP13 in prostatic cancer, thereby possibly attenuating metastasis (Wang et al., 2021)